Statements (52)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:virus
|
| gptkbp:affects |
immunocompromised individuals
|
| gptkbp:belongs_to |
Herpesviridae family
|
| gptkbp:can_be_found_in |
breast milk
saliva urine semen |
| gptkbp:can_cause |
congenital infection
|
| gptkbp:can_detect |
PCR testing
|
| gptkbp:can_lead_to |
vision problems
hearing loss developmental delays |
| gptkbp:cause |
cytomegalovirus infection
|
| gptkbp:diagnosis |
serology
|
| gptkbp:difficulty_levels |
newborns
organ transplant recipients HIV patients |
| https://www.w3.org/2000/01/rdf-schema#label |
Cytomegalovirus
|
| gptkbp:is_associated_with |
gptkb:pneumonia
gptkb:multiple_sclerosis gastrointestinal disease retinitis |
| gptkbp:is_common_in |
developing countries
pregnant women immunocompromised patients |
| gptkbp:is_considered |
opportunistic infection
|
| gptkbp:is_known_to |
affect fetal development
be a significant cause of morbidity be asymptomatic in healthy adults be prevalent worldwide cause complications in pregnancy cause mononucleosis-like symptoms have a latent phase reactivate after organ transplantation reactivate in immunosuppressed patients |
| gptkbp:is_less_severe_in |
healthy individuals
|
| gptkbp:is_part_of |
herpesvirus research
|
| gptkbp:is_related_to |
other herpesviruses
|
| gptkbp:is_studied_for |
therapeutic interventions
vaccine development |
| gptkbp:is_studied_in |
gptkb:medical_research
|
| gptkbp:is_vaccine_available |
no
|
| gptkbp:known_as |
CMV
|
| gptkbp:prevention |
hygiene practices
|
| gptkbp:symptoms |
fatigue
fever muscle aches swollen glands |
| gptkbp:transmission |
bodily fluids
|
| gptkbp:treatment |
antiviral medications
|
| gptkbp:bfsParent |
gptkb:multiple_sclerosis
|
| gptkbp:bfsLayer |
4
|